hVIVO plc is a specialist contract research organisation focused on human challenge clinical trials and early-stage infectious disease research. The company partners with pharmaceutical and biotechnology clients to accelerate the development of vaccines, antiviral therapies, and respiratory disease treatments through highly specialised clinical services. …
Provexis shares stood at 1.00p on July 30, 2026, down 15.25% on the session. Quoted in pence rather than pounds or a foreign currency, that is a fall of a fraction of a penny in absolute terms, not a large monetary move per share. …
The London line 0EAP is an international order-book quotation of EUROAPI SA, whose primary listing is on Euronext Paris; crucially, it is priced in euros, not pence, so the €0.922 quote and the roughly €93 million market capitalization both reflect the company's home currency. …
By lunchtime on July 30, 2026 the stock traded at 13.50p, down 18.18% on the session, per London South East; stockanalysis.com records the group's market capitalization has roughly halved over the past twelve months. The move is harder to read for the absence of …
The decline was among the steepest single-day falls in Pharming's recent history and tracked its Amsterdam listing. At 07:00 CET on July 30, 2026, Pharming released its interim figures and revised down its outlook for the remainder of 2026. Management now expects full-year total …
Shield's shares changed hands at 4.40p on July 30, 2026, down 23.48%, according to London South East (lse.co.uk) data captured at 13:01 UK time. The shares are ordinary shares of 1.5p each, quoted in pence sterling (GBX) on London's AIM market, not the US …
Oxford Biomedica plc is a biotechnology company specializing in the development and manufacture of cell and gene therapies. The company operates as a contract development and manufacturing organization (CDMO), helping biotechnology and pharmaceutical companies move innovative therapies from research through commercial production. Its expertise …
As of the latest session, Oxford Nanopore Technologies PLC (ONT) shares were trading at 113.60p, up +1.20p (+1.07%) on the day.
Oxford BioMedica plc is a UK-based biopharmaceutical company specialising in the development and manufacture of viral vectors used in gene and cell therapies. The company partners with pharmaceutical and biotechnology companies globally to provide manufacturing services supporting advanced therapy medicinal products. Investor sentiment improved …
Ondine Biomedical Inc. develops light-activated antimicrobial therapies designed to prevent healthcare-associated infections. Its flagship Steriwave technology aims to reduce surgical site infections and other hospital-acquired infections without relying on conventional antibiotics. The recent strength in the company's share price reflects improving investor confidence following …